ExpreS2ion (public company)

ExpreS2ion Biotechnologies is a world leading contract research organisation within production in Drosophila Schneider-2 (S2) cells.

ExpreS2ion Biotechnologies ApS was founded in 2010 as a spin out of the S2 expression platform from the Danish company Affitech A/S.

The founders were scientists who had developed the platform as employees of initially Pharmexa A/S and following Affitech A/S.

In 2016, ExpreS2ion Biotech Holding AB was founded.